OpenJournalRank
Compare

Journal rankings · indicator year 2025

Choose a field to open its ranking, or a journal to find its row in its subfield’s list.

Subfield ranking · 2025

Neurology journal rankings 2025

168 ranked journals · Subfield in Medicine

Neurology has 168 ranked journals in 2025. The median journal has an OJR of 0.62, below the world average of 1.00, up 0.03 on 2024; Q1 starts at OJR 1.02. The three highest-scoring journals with stable ranks are The Lancet Neurology, Translational Neurodegeneration, and JAMA Neurology: each is likely ranked within the top 3.

Ranks and citation indicators: 2025. Journal access status and listed APC: source snapshot September 23, 2026.

Ranked journals

Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2022–2024, the window the 2025 score is computed on.

168
4% of Medicine
Median OJR

The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.

The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.

The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.

0.62+0.03 vs 2024
This subfieldAll 0.78World 1.00
Open-access journals

Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.

49%
All fields: 38%
Median listed APC

Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.

$3,425
Median positive listed APC: $3,425 among 82 journals. Another 4 list $0; 82 have no known price. All fields: $3,200.

Subfields of Medicine (42)

Show all 42 subfields

168 ranked journals

Filters

Quartile

Quartiles split the ranked journals of the list you are viewing into four equal groups by OJR. Q1 is the top quarter and Q4 the bottom quarter.

They are computed within the list on screen, so a journal can be Q1 in its subfield and Q2 in the global ranking.

Access
APC (list price)
Loading every ranked journal in this list…
Neurology ranking, 2025

Rank is the position by OJR within the list on screen; 1 is the highest.

The small range under it is the likely rank range: in 95% of 1,000 resamples of the journal’s papers, it ranked inside that range. Journals whose ranges overlap are not clearly different.

OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields.

The badge is the journal’s quartile in this list.

OJR

Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field.

▲ or ▼ is the change from 2024. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor.

Citable documents (articles, reviews and conference papers) published in 2022–2024, the window the 2025 OJR is computed on. A journal needs at least 30 to be ranked.

Share of the journal’s 2022–2024 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal.

List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed.

The line is the journal’s OJR from 2016 to 2025.

A label compares the 2022→2025 change with the median change of the journal’s field or domain. Rising needs a relative change of +10% or more that is at least 2 standard errors above zero; Falling needs -9.1% or less (rounded), at least 2 standard errors below zero. Sorting uses that relative change.

Compare
Rank 1; likely between #1 and #2 of 168The Lancet NeurologyElsevier BV · Netherlands
7.33Q119.32 1.22 up from 202462233%$7,280
Rank 2; likely between #1 and #3 of 168Translational NeurodegenerationOABioMed Central · China
5.46Q116.98 0.58 up from 2024175100%$2,990Rising vs field, 2022–25
Rank 3; likely between #2 and #3 of 168JAMA NeurologyAmerican Medical Association · United States
4.79Q112.37 0.54 up from 202468452%—
Rank 4; likely between #4 and #6 of 168BrainOxford University Press · United Kingdom
3.20Q110.01 0.45 up from 20241,25476%$5,570
Rank 5; likely between #4 and #7 of 168npj Parkinson s DiseaseOANature Portfolio · United States
3.06Q19.13 0.02 down from 2024553100%$3,890
Rank 6; likely between #4 and #9 of 168Nature Reviews NeurologyNature Portfolio · United Kingdom
2.91Q113.73 1.96 up from 202441818%—
Rank 7; likely between #4 and #11 of 168Current Neurology and Neuroscience ReportsSpringer Science+Business Media · United States
2.74Q18.43 1.85 up from 202422737%$5,590
Rank 8; likely between #6 and #11 of 168NeurotherapeuticsOASpringer Science+Business Media · United States
2.51Q17.32 0.15 down from 2024432100%$3,900Rising vs field, 2022–25
Rank 9; likely between #6 and #10 of 168Annals of NeurologyWiley · United States
2.49Q17.02 0.26 up from 202470671%$4,700
Rank 10; likely between #7 and #11 of 168Neurology Neuroimmunology & NeuroinflammationOAWolters Kluwer · United States
2.36Q16.16 1.42 down from 2024392100%$3,450
Rank 11; likely between #9 and #12 of 168Journal of Neurology Neurosurgery & PsychiatryBMJ · United Kingdom
2.24Q16.48 0.52 down from 202454454%—
Rank 12; likely between #12 and #16 of 168CNS Neuroscience & TherapeuticsOAWiley · United Kingdom
1.96Q16.63 1.41 up from 20241,207100%$4,140
Rank 13; likely between #11 and #17 of 168Acta Neuropathologica CommunicationsOASpringer Science+Business Media · United Kingdom
1.93Q16.54 0.30 up from 2024569100%$3,790
Rank 14; likely between #12 and #17 of 168Neurobiology of DiseaseOAElsevier BV · United States
1.91Q16.18 0.01 down from 2024943100%$4,180
Rank 15; likely between #12 and #19 of 168Movement DisordersWiley · United States
1.89Q15.79 0.11 down from 202493173%$4,480
Rank 16; likely between #13 and #18 of 168NeurologyLippincott Williams & Wilkins · United States
1.85Q15.15 0.14 up from 20242,65311%—
Rank 17; likely between #13 and #22 of 168Journal of Parkinson s DiseaseOAIOS Press · Netherlands
1.74Q15.66 1.07 up from 2024449100%—Rising vs field, 2022–25
Rank 18; likely between #14 and #24 of 168Current Opinion in NeurologyLippincott Williams & Wilkins · United States
1.67Q15.23 0.21 up from 202425635%—
Rank 19; likely between #17 and #22 of 168Frontiers in Aging NeuroscienceOAFrontiers Media · Switzerland
1.65Q15.62 0.40 up from 20242,882100%$3,801
Rank 20; likely between #18 and #26 of 168Journal of Cerebral Blood Flow & MetabolismSAGE Publishing · United Kingdom
1.56Q14.78 0.07 up from 202451794%$4,200
Rank 21; likely between #16 and #31 of 168CONTINUUM Lifelong Learning in NeurologyLippincott Williams & Wilkins · United States
1.52Q12.89 2.10 down from 20242146%—
Rank 22; likely between #18 and #29 of 168Journal of Neural TransmissionSpringer Science+Business Media · Austria
1.50Q14.87 0.19 up from 202438754%$4,690Rising vs field, 2022–25
Rank 23; likely between #20 and #27 of 168Journal of NeurologySpringer Science+Business Media · Germany
1.48Q15.14 0.53 up from 20241,77053%$4,790
Rank 24; likely between #20 and #28 of 168Annals of Clinical and Translational NeurologyOAWiley · United States
1.48Q14.30 0.18 down from 2024743100%$4,100
Rank 25; likely between #18 and #34 of 168Therapeutic Advances in Neurological DisordersOASAGE Publishing · United Kingdom
1.43Q14.35 0.36 down from 2024268100%$2,650Falling vs field, 2022–25
Rank 26; likely between #22 and #29 of 168European Journal of NeurologyOAWiley · United Kingdom
1.42Q14.51 0.53 up from 20241,247100%$3,600
Rank 27; likely between #18 and #35 of 168NeuroepidemiologyKarger Publishers · Switzerland
1.41Q13.08 1.53 down from 202417240%—
Rank 28; likely between #25 and #32 of 168Journal of neurosurgeryAmerican Association of Neurological Surgeons · United States
1.32Q13.60 0.08 up from 20241,05415%—
Rank 29; likely between #25 and #35 of 168Translational Stroke ResearchSpringer Science+Business Media · United States
1.29Q14.15 0.16 down from 202432441%$5,490Falling vs field, 2022–25
Rank 30; likely between #27 and #39 of 168Neurocritical CareSpringer Science+Business Media · United States
1.22Q13.77 0.32 up from 202469232%$4,690Rising vs field, 2022–25
Rank 31; likely between #24 and #48 of 168Brain CirculationOAMedknow · India
1.21Q14.72 0.03 down from 2024138100%—Rising vs field, 2022–25
Rank 32; likely between #28 and #38 of 168Neurosurgical FOCUSOAAmerican Association of Neurological Surgeons · United States
1.20Q13.55 0.36 up from 2024441100%—Falling vs field, 2022–25
Rank 33; likely between #27 and #50 of 168Neurological Research and PracticeOABioMed Central · United Kingdom
1.15Q14.04 0.91 up from 2024184100%$2,190
Rank 34; likely between #30 and #42 of 168American Journal of NeuroradiologyAmerican Society of Neuroradiology · United States
1.14Q13.54 0.14 up from 2024925100%—
Rank 35; likely between #31 and #44 of 168Parkinsonism & Related DisordersElsevier BV · United Kingdom
1.12Q13.48 0.64 up from 202492420%$3,460Rising vs field, 2022–25
Rank 36; likely between #29 and #51 of 168Neurology InternationalOAPAGEPress (Italy) · Switzerland
1.11Q13.68 0.10 up from 2024306100%$1,930
Rank 37; likely between #18 and #79 of 168Neurodegenerative Disease ManagementFuture Medicine · United Kingdom
1.09Q12.61 1.15 down from 20246594%—
Rank 38; likely between #35 and #43 of 168Frontiers in NeurologyOAFrontiers Media · Switzerland
1.07Q13.64 0.33 up from 20247,371100%$3,801Falling vs field, 2022–25
Rank 39; likely between #30 and #55 of 168Neurosurgery Clinics of North AmericaElsevier BV · United States
1.07Q12.62 0.34 up from 20241695%$3,000
Rank 40; likely between #22 and #70 of 168Journal of NeurorestoratologyOAElsevier BV · China
1.04Q13.25 0.15 down from 2024105100%$1,700
Rank 41; likely between #37 and #51 of 168NeurosurgeryLippincott Williams & Wilkins · United States
1.02Q13.06 0.13 down from 20241,1365%—
Rank 42; likely between #26 and #72 of 168Neurologia medico-chirurgicaOAJapan Neurological Society · Japan
1.02Q11.88 1.15 down from 2024196100%$75
Rank 43; likely between #34 and #56 of 168Seminars in NeurologyThieme Medical Publishers (Germany) · United States
1.01Q22.54 0.10 up from 20242239%—Falling vs field, 2022–25
Rank 44; likely between #35 and #57 of 168BMJ Neurology OpenOABMJ
1.00Q22.92 0.02 down from 2024192100%—
Rank 44; likely between #36 and #55 of 168Journal of Integrative NeuroscienceOAImperial College Press · Hong Kong SAR China
1.00Q23.56 0.49 up from 2024567100%$1,900Rising vs field, 2022–25
Rank 46; likely between #35 and #61 of 168Neuroimaging Clinics of North AmericaElsevier BV · United States
0.97Q21.93 0.45 down from 202414318%$3,000
Rank 47; likely between #36 and #58 of 168NeuroradiologySpringer Science+Business Media · Germany
0.97Q22.99 0.11 up from 202457831%$4,790
Rank 48; likely between #37 and #58 of 168Journal of the Neurological SciencesElsevier BV · Netherlands
0.97Q22.63 0.40 down from 20249807%$3,640
Rank 49; likely between #43 and #55 of 168BMC NeurologyOABioMed Central · United Kingdom
0.95Q22.94 0.24 up from 20241,422100%$3,090
Rank 50; likely between #35 and #63 of 168Parkinson s DiseaseOAHindawi Publishing Corporation · United Kingdom
0.95Q22.10 0.31 down from 2024103100%$2,160

The endpoints below each rank show its likely range. How rank ranges are calculated

Citations made in 2025. Corpus-wide, 84.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.

26 additional Neurology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2022–2024, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.

Rising journals

At a glance

Indicator year: 2025. Publication window: 2022–2024. How these summaries are calculated

Ranked journals
168
Window papers (baseline)
89,484 +10.5% from indicator year 2022
Median OJR
0.62 +4.1% from indicator year 2022
Rising journals (2025)
16

Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2022–2024 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.

Category by indicator year
MeasureYear series20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025
Ranked journals6263646868768286858795109120132138151151157161164170172176174175168
Window papers (baseline)20,10322,21223,09224,51125,42327,79830,11932,96635,57439,47142,31545,18546,65948,51851,65753,86756,14756,82158,52960,56063,29571,05780,97188,94290,22589,484
Median OJR0.420.480.530.6020.64950.7310.720.740.870.840.810.760.7320.6620.680.6570.64920.6390.670.6440.6610.570.5980.6010.590.62

How to read these rankings

OJR, the OpenJournalRank Indicator
A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
Quartiles
Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
Impact factor (2-year)
Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
Rank ranges
Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.